XML 57 R2.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Per Share data
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Net sales$ 516,514$ 471,502$ 1,523,291$ 1,393,398
Cost of goods sold220,338205,172656,368601,633
Gross profit296,176266,330866,923791,765
Selling, general and administrative expense176,867148,654521,370458,541
Research and development expense45,38742,874136,327126,999
Income from operations73,92274,802209,226206,225
Interest expense12,34114,40041,14843,169
Foreign exchange losses, net6,3462,74912,1323,546
Other (income) expense, net(538)(256)(5,907)(3,572)
Income before income taxes55,77357,909161,853163,082
Provision for income taxes(9,911)(12,824)(43,031)(44,084)
Net income including noncontrolling interests45,86245,085118,822118,998
Net loss (income) attributable to noncontrolling interests35(321)162(1,416)
Net income attributable to Bio-Rad$ 45,897$ 44,764$ 118,984$ 117,582
Basic earnings per share:    
Net income per share basic attributable to Bio-Rad$ 1.63$ 1.62$ 4.25$ 4.26
Weighted average common shares - basic28,07227,69727,99727,616
Diluted earnings per share:    
Net income per share diluted attributable to Bio-Rad$ 1.61$ 1.59$ 4.18$ 4.18
Weighted average common shares - diluted28,45628,10328,45428,110